Zobrazeno 1 - 10
of 53
pro vyhledávání: '"O. V. Tsygankova"'
Publikováno v:
Сахарный диабет, Vol 27, Iss 4, Pp 357-367 (2024)
BACKGROUND: Considering the role of visceral adipose tissue deposition in the pathogenesis of heart failure with preserved ejection fraction (HFpEF) and the positive effect of metformin on weight loss, the effect of this drug on adipose tissue compar
Externí odkaz:
https://doaj.org/article/f01164e484d44d8faa7fe6fc672f4705
Publikováno v:
Сахарный диабет, Vol 25, Iss 6, Pp 535-547 (2023)
Insulin resistance, which is a fundamental pathogenetic factor of prediabetes, is closely associated with abdominal obesity on the one hand and the development of cardiovascular diseases, heart failure (HF), on the other. The pathogenetic role of ins
Externí odkaz:
https://doaj.org/article/c7ae68673d334d949c1d098d73a62104
Publikováno v:
Сибирский научный медицинский журнал, Vol 42, Iss 6, Pp 4-14 (2022)
Chronic heart failure is a global cardiac problem. The last decade can rightly be called a breakthrough in the treatment of this nosology, due to the emergence of a new group of drugs – SGLT2 inhibitors (gliflozins), which, both in patients with in
Externí odkaz:
https://doaj.org/article/e124ef8e198e4b14b4fb7eda952fac90
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 2, Pp 183-190 (2022)
Nonspecific aortoarteritis (Takayasu's disease) is a systemic inflammatory disease characterized by granulomatous lesions of the aorta and its large branches. The article describes the clinical manifestations, methods of diagnosis and treatment of th
Externí odkaz:
https://doaj.org/article/df8ffadf9aff426eba75f6878e029170
Autor:
O. V. Tsygankova, N. E. Evdokimova, Yu. I. Ragino, L. D. Latyntseva, V. V. Veretyuk, A. A. Starichkova
Publikováno v:
Атеросклероз, Vol 17, Iss 1, Pp 21-28 (2021)
Aim of the study was to evaluate the serum concentrations of three marker lysosomal hydrolases (cathepsin D, acid phosphatase (AP) and acid DNase (aDNAase)) in women with coronary heart disease (CHD) depending on the level of follicle-stimulating h
Externí odkaz:
https://doaj.org/article/f5913a59a6ba4e90a8b5768bb460dbdd
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 4, Pp 557-563 (2020)
Primary hyperaldosteronism is an existence of a functional autonomous source with increased aldosterone production (full or partial) in relation to the renin-angiotensin system. Increased production of aldosterone by the adrenal cortex is the most co
Externí odkaz:
https://doaj.org/article/a2b7441e948e4491b2bb240aac39b4a8
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 18, Iss 6, Pp 116-120 (2019)
The clinical case of the successful use of the myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in a patient with hemodynamic angina due to myocardial bridging is described. The pathogenetic rationale for this prescription is
Externí odkaz:
https://doaj.org/article/8544dbd9cbf5426298ee20f5f4c0f666
Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
Autor:
V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 5, Pp 663-669 (2019)
Aim. To evaluate the therapeutic efficacy of a combination of ivabradine and beta-blockers (BAB) in patients with stable angina, initially taking only BAB and not reaching the target heart rate (HR) due to the risk of hypotension.Material and methods
Externí odkaz:
https://doaj.org/article/8451edf3d9fa44d782bacf0a6edbd820
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 11 (2021)
Rhabdomyolysis is a very rare and most severe form of statin-induced muscle adverse event characterized by muscle pain, muscle necrosis with myoglobinemia and/or myoglobinuria with a very high risk of acute kidney injury and death. The article presen
Externí odkaz:
https://doaj.org/article/2c2e5f97eefb4b1aae1def2c6bb65e1c
Autor:
O. V. Tsygankova, V. V. Veretyuk
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 4 (2021)
The problems of heart failure (HF) are becoming increasingly important every year due to the increasing spread of cardiovascular diseases resulting in its development, as well as the impact of metabolic factors, obesity, drugs and endocrine dysfuncti
Externí odkaz:
https://doaj.org/article/a50a46d4104949e88e8dfb8567787cef